go back

Idecabtagene Vicleucel (Abecma) CAR-T Therapy

Wyoming rates for HCPCS Q2055

Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated October 2026.

How much rates vary

Facilitymedian $562,341 · 10th to 90th $562,341 to $562,341Professionalmedian $562,341 · 10th to 90th $549,541 to $645,654
facility $562,341professional $562,341

Distribution of negotiated rates across all payers (price axis is log-scale). Small sample; interpret with caution. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Aetna
Setting
Facility
Modifier
None
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$562,341.33
Aetna
Setting
Professional
Modifier
None
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$562,341.33
BCBS Wyoming
Setting
Professional
Modifier
None
Typical Low
$549,540.87
Median
$645,654.23
Typical High
$645,654.23
BCBS Wyoming
Setting
Professional
Modifier
53 · Discontinued
Typical Low
$389,045.14
Median
$457,088.19
Typical High
$457,088.19